Autism Spectrum Disorder Treatment Market, Global Outlook and Forecast 2022-2028

July 2022 | 67 pages | ID: A1D9B4EC83B4EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Autism Spectrum Disorder Treatment in Global, including the following market information:

Global Autism Spectrum Disorder Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Autism Spectrum Disorder Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Behavioral Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Autism Spectrum Disorder Treatment include Q BioMed Inc., PaxMedica, Yamo Pharmaceuticals, Otsuka Pharmaceutical Co., Ltd., F. Hoffmann-La Roche Ltd, Curemark, LLC, Zynerba Pharmaceuticals, Inc, Axial Therapeutics and Novartis AG and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Autism Spectrum Disorder Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Autism Spectrum Disorder Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Autism Spectrum Disorder Treatment Market Segment Percentages, by Type, 2021 (%)

• Behavioral Therapy
• Educational Therapy
• Family Counseling
• Speech and Language Therapy
• Medical Treatement

Global Autism Spectrum Disorder Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Autism Spectrum Disorder Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Home
• Others

Global Autism Spectrum Disorder Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Autism Spectrum Disorder Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Autism Spectrum Disorder Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Autism Spectrum Disorder Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Q BioMed Inc.
• PaxMedica
• Yamo Pharmaceuticals
• Otsuka Pharmaceutical Co., Ltd.
• F. Hoffmann-La Roche Ltd
• Curemark, LLC
• Zynerba Pharmaceuticals, Inc
• Axial Therapeutics
• Novartis AG
• STALICLA

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Autism Spectrum Disorder Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Autism Spectrum Disorder Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL AUTISM SPECTRUM DISORDER TREATMENT OVERALL MARKET SIZE

2.1 Global Autism Spectrum Disorder Treatment Market Size: 2021 VS 2028
2.2 Global Autism Spectrum Disorder Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Autism Spectrum Disorder Treatment Players in Global Market
3.2 Top Global Autism Spectrum Disorder Treatment Companies Ranked by Revenue
3.3 Global Autism Spectrum Disorder Treatment Revenue by Companies
3.4 Top 3 and Top 5 Autism Spectrum Disorder Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Autism Spectrum Disorder Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Autism Spectrum Disorder Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Autism Spectrum Disorder Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Autism Spectrum Disorder Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Autism Spectrum Disorder Treatment Market Size Markets, 2021 & 2028
  4.1.2 Behavioral Therapy
  4.1.3 Educational Therapy
  4.1.4 Family Counseling
  4.1.5 Speech and Language Therapy
  4.1.6 Medical Treatement
4.2 By Type - Global Autism Spectrum Disorder Treatment Revenue & Forecasts
  4.2.1 By Type - Global Autism Spectrum Disorder Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Autism Spectrum Disorder Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Autism Spectrum Disorder Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Autism Spectrum Disorder Treatment Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinics
  5.1.4 Home
  5.1.5 Others
5.2 By Application - Global Autism Spectrum Disorder Treatment Revenue & Forecasts
  5.2.1 By Application - Global Autism Spectrum Disorder Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Autism Spectrum Disorder Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Autism Spectrum Disorder Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Autism Spectrum Disorder Treatment Market Size, 2021 & 2028
6.2 By Region - Global Autism Spectrum Disorder Treatment Revenue & Forecasts
  6.2.1 By Region - Global Autism Spectrum Disorder Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Autism Spectrum Disorder Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Autism Spectrum Disorder Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Autism Spectrum Disorder Treatment Revenue, 2017-2028
  6.3.2 US Autism Spectrum Disorder Treatment Market Size, 2017-2028
  6.3.3 Canada Autism Spectrum Disorder Treatment Market Size, 2017-2028
  6.3.4 Mexico Autism Spectrum Disorder Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Autism Spectrum Disorder Treatment Revenue, 2017-2028
  6.4.2 Germany Autism Spectrum Disorder Treatment Market Size, 2017-2028
  6.4.3 France Autism Spectrum Disorder Treatment Market Size, 2017-2028
  6.4.4 U.K. Autism Spectrum Disorder Treatment Market Size, 2017-2028
  6.4.5 Italy Autism Spectrum Disorder Treatment Market Size, 2017-2028
  6.4.6 Russia Autism Spectrum Disorder Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Autism Spectrum Disorder Treatment Market Size, 2017-2028
  6.4.8 Benelux Autism Spectrum Disorder Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Autism Spectrum Disorder Treatment Revenue, 2017-2028
  6.5.2 China Autism Spectrum Disorder Treatment Market Size, 2017-2028
  6.5.3 Japan Autism Spectrum Disorder Treatment Market Size, 2017-2028
  6.5.4 South Korea Autism Spectrum Disorder Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Autism Spectrum Disorder Treatment Market Size, 2017-2028
  6.5.6 India Autism Spectrum Disorder Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Autism Spectrum Disorder Treatment Revenue, 2017-2028
  6.6.2 Brazil Autism Spectrum Disorder Treatment Market Size, 2017-2028
  6.6.3 Argentina Autism Spectrum Disorder Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Autism Spectrum Disorder Treatment Revenue, 2017-2028
  6.7.2 Turkey Autism Spectrum Disorder Treatment Market Size, 2017-2028
  6.7.3 Israel Autism Spectrum Disorder Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Autism Spectrum Disorder Treatment Market Size, 2017-2028
  6.7.5 UAE Autism Spectrum Disorder Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Q BioMed Inc.
  7.1.1 Q BioMed Inc. Corporate Summary
  7.1.2 Q BioMed Inc. Business Overview
  7.1.3 Q BioMed Inc. Autism Spectrum Disorder Treatment Major Product Offerings
  7.1.4 Q BioMed Inc. Autism Spectrum Disorder Treatment Revenue in Global Market (2017-2022)
  7.1.5 Q BioMed Inc. Key News
7.2 PaxMedica
  7.2.1 PaxMedica Corporate Summary
  7.2.2 PaxMedica Business Overview
  7.2.3 PaxMedica Autism Spectrum Disorder Treatment Major Product Offerings
  7.2.4 PaxMedica Autism Spectrum Disorder Treatment Revenue in Global Market (2017-2022)
  7.2.5 PaxMedica Key News
7.3 Yamo Pharmaceuticals
  7.3.1 Yamo Pharmaceuticals Corporate Summary
  7.3.2 Yamo Pharmaceuticals Business Overview
  7.3.3 Yamo Pharmaceuticals Autism Spectrum Disorder Treatment Major Product Offerings
  7.3.4 Yamo Pharmaceuticals Autism Spectrum Disorder Treatment Revenue in Global Market (2017-2022)
  7.3.5 Yamo Pharmaceuticals Key News
7.4 Otsuka Pharmaceutical Co., Ltd.
  7.4.1 Otsuka Pharmaceutical Co., Ltd. Corporate Summary
  7.4.2 Otsuka Pharmaceutical Co., Ltd. Business Overview
  7.4.3 Otsuka Pharmaceutical Co., Ltd. Autism Spectrum Disorder Treatment Major Product Offerings
  7.4.4 Otsuka Pharmaceutical Co., Ltd. Autism Spectrum Disorder Treatment Revenue in Global Market (2017-2022)
  7.4.5 Otsuka Pharmaceutical Co., Ltd. Key News
7.5 F. Hoffmann-La Roche Ltd
  7.5.1 F. Hoffmann-La Roche Ltd Corporate Summary
  7.5.2 F. Hoffmann-La Roche Ltd Business Overview
  7.5.3 F. Hoffmann-La Roche Ltd Autism Spectrum Disorder Treatment Major Product Offerings
  7.5.4 F. Hoffmann-La Roche Ltd Autism Spectrum Disorder Treatment Revenue in Global Market (2017-2022)
  7.5.5 F. Hoffmann-La Roche Ltd Key News
7.6 Curemark, LLC
  7.6.1 Curemark, LLC Corporate Summary
  7.6.2 Curemark, LLC Business Overview
  7.6.3 Curemark, LLC Autism Spectrum Disorder Treatment Major Product Offerings
  7.6.4 Curemark, LLC Autism Spectrum Disorder Treatment Revenue in Global Market (2017-2022)
  7.6.5 Curemark, LLC Key News
7.7 Zynerba Pharmaceuticals, Inc
  7.7.1 Zynerba Pharmaceuticals, Inc Corporate Summary
  7.7.2 Zynerba Pharmaceuticals, Inc Business Overview
  7.7.3 Zynerba Pharmaceuticals, Inc Autism Spectrum Disorder Treatment Major Product Offerings
  7.7.4 Zynerba Pharmaceuticals, Inc Autism Spectrum Disorder Treatment Revenue in Global Market (2017-2022)
  7.7.5 Zynerba Pharmaceuticals, Inc Key News
7.8 Axial Therapeutics
  7.8.1 Axial Therapeutics Corporate Summary
  7.8.2 Axial Therapeutics Business Overview
  7.8.3 Axial Therapeutics Autism Spectrum Disorder Treatment Major Product Offerings
  7.8.4 Axial Therapeutics Autism Spectrum Disorder Treatment Revenue in Global Market (2017-2022)
  7.8.5 Axial Therapeutics Key News
7.9 Novartis AG
  7.9.1 Novartis AG Corporate Summary
  7.9.2 Novartis AG Business Overview
  7.9.3 Novartis AG Autism Spectrum Disorder Treatment Major Product Offerings
  7.9.4 Novartis AG Autism Spectrum Disorder Treatment Revenue in Global Market (2017-2022)
  7.9.5 Novartis AG Key News
7.10 STALICLA
  7.10.1 STALICLA Corporate Summary
  7.10.2 STALICLA Business Overview
  7.10.3 STALICLA Autism Spectrum Disorder Treatment Major Product Offerings
  7.10.4 STALICLA Autism Spectrum Disorder Treatment Revenue in Global Market (2017-2022)
  7.10.5 STALICLA Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Autism Spectrum Disorder Treatment Market Opportunities & Trends in Global Market
Table 2. Autism Spectrum Disorder Treatment Market Drivers in Global Market
Table 3. Autism Spectrum Disorder Treatment Market Restraints in Global Market
Table 4. Key Players of Autism Spectrum Disorder Treatment in Global Market
Table 5. Top Autism Spectrum Disorder Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Autism Spectrum Disorder Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Autism Spectrum Disorder Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Autism Spectrum Disorder Treatment Product Type
Table 9. List of Global Tier 1 Autism Spectrum Disorder Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Autism Spectrum Disorder Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Autism Spectrum Disorder Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Autism Spectrum Disorder Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Autism Spectrum Disorder Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Autism Spectrum Disorder Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Autism Spectrum Disorder Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Autism Spectrum Disorder Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Autism Spectrum Disorder Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Autism Spectrum Disorder Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Autism Spectrum Disorder Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Autism Spectrum Disorder Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Autism Spectrum Disorder Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Autism Spectrum Disorder Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Autism Spectrum Disorder Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Autism Spectrum Disorder Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Autism Spectrum Disorder Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Autism Spectrum Disorder Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Autism Spectrum Disorder Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Autism Spectrum Disorder Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Autism Spectrum Disorder Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Q BioMed Inc. Corporate Summary
Table 31. Q BioMed Inc. Autism Spectrum Disorder Treatment Product Offerings
Table 32. Q BioMed Inc. Autism Spectrum Disorder Treatment Revenue (US$, Mn), (2017-2022)
Table 33. PaxMedica Corporate Summary
Table 34. PaxMedica Autism Spectrum Disorder Treatment Product Offerings
Table 35. PaxMedica Autism Spectrum Disorder Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Yamo Pharmaceuticals Corporate Summary
Table 37. Yamo Pharmaceuticals Autism Spectrum Disorder Treatment Product Offerings
Table 38. Yamo Pharmaceuticals Autism Spectrum Disorder Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Otsuka Pharmaceutical Co., Ltd. Corporate Summary
Table 40. Otsuka Pharmaceutical Co., Ltd. Autism Spectrum Disorder Treatment Product Offerings
Table 41. Otsuka Pharmaceutical Co., Ltd. Autism Spectrum Disorder Treatment Revenue (US$, Mn), (2017-2022)
Table 42. F. Hoffmann-La Roche Ltd Corporate Summary
Table 43. F. Hoffmann-La Roche Ltd Autism Spectrum Disorder Treatment Product Offerings
Table 44. F. Hoffmann-La Roche Ltd Autism Spectrum Disorder Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Curemark, LLC Corporate Summary
Table 46. Curemark, LLC Autism Spectrum Disorder Treatment Product Offerings
Table 47. Curemark, LLC Autism Spectrum Disorder Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Zynerba Pharmaceuticals, Inc Corporate Summary
Table 49. Zynerba Pharmaceuticals, Inc Autism Spectrum Disorder Treatment Product Offerings
Table 50. Zynerba Pharmaceuticals, Inc Autism Spectrum Disorder Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Axial Therapeutics Corporate Summary
Table 52. Axial Therapeutics Autism Spectrum Disorder Treatment Product Offerings
Table 53. Axial Therapeutics Autism Spectrum Disorder Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Novartis AG Corporate Summary
Table 55. Novartis AG Autism Spectrum Disorder Treatment Product Offerings
Table 56. Novartis AG Autism Spectrum Disorder Treatment Revenue (US$, Mn), (2017-2022)
Table 57. STALICLA Corporate Summary
Table 58. STALICLA Autism Spectrum Disorder Treatment Product Offerings
Table 59. STALICLA Autism Spectrum Disorder Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Autism Spectrum Disorder Treatment Segment by Type in 2021
Figure 2. Autism Spectrum Disorder Treatment Segment by Application in 2021
Figure 3. Global Autism Spectrum Disorder Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Autism Spectrum Disorder Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Autism Spectrum Disorder Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Autism Spectrum Disorder Treatment Revenue in 2021
Figure 8. By Type - Global Autism Spectrum Disorder Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Autism Spectrum Disorder Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Autism Spectrum Disorder Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Autism Spectrum Disorder Treatment Revenue Market Share, 2017-2028
Figure 12. US Autism Spectrum Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Autism Spectrum Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Autism Spectrum Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Autism Spectrum Disorder Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Autism Spectrum Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Autism Spectrum Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Autism Spectrum Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Autism Spectrum Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Autism Spectrum Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Autism Spectrum Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Autism Spectrum Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Autism Spectrum Disorder Treatment Revenue Market Share, 2017-2028
Figure 24. China Autism Spectrum Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Autism Spectrum Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Autism Spectrum Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Autism Spectrum Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Autism Spectrum Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Autism Spectrum Disorder Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Autism Spectrum Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Autism Spectrum Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Autism Spectrum Disorder Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Autism Spectrum Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Autism Spectrum Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Autism Spectrum Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Autism Spectrum Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Q BioMed Inc. Autism Spectrum Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. PaxMedica Autism Spectrum Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Yamo Pharmaceuticals Autism Spectrum Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Otsuka Pharmaceutical Co., Ltd. Autism Spectrum Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. F. Hoffmann-La Roche Ltd Autism Spectrum Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Curemark, LLC Autism Spectrum Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Zynerba Pharmaceuticals, Inc Autism Spectrum Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Axial Therapeutics Autism Spectrum Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Novartis AG Autism Spectrum Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. STALICLA Autism Spectrum Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)